Clinical Trials Directory

Trials / Sponsors / BerGenBio ASA

BerGenBio ASA

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-
Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 22023-03-03
CompletedA Study to Investigate 14C-bemcentinib in Healthy Male Subjects
Non-Small Cell Lung Cancer, Metastatic Melanoma, Acute Myeloid Leukemia
Phase 12022-08-02
TerminatedA Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Part
Ovarian Neoplasms
Phase 12021-02-25
CompletedA Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients
COVID-19
Phase 22020-10-20
CompletedA First-time-in-human Study of BGB149
Healthy Volunteers
EARLY_Phase 12018-12-19
CompletedBemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (N
Lung Cancer Metastatic, NSCLC Stage IV, Adenocarcinoma of Lung
Phase 22017-10-02
TerminatedBemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC
Triple Negative Breast Cancer, Inflammatory Breast Cancer Stage IV
Phase 22017-07-26
CompletedA Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Phase 1 / Phase 22015-04-19
CompletedA Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 1 / Phase 22014-10-22